Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Tech Tuesday: University of Florida Startup Aims To Improve How Polymers Are Made
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey interviews Gregory Kis, CEO of Oboro Labs and winner of the Panelists’ Choice award in the established companies category at the spring GatorPitch Miami event.
Genascence Phase 1b DONATELLO Trial Evaluating Potential First-in-Class Gene Therapy for Knee Osteoarthritis (OA) Meets Primary Endpoint Showing GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation announced positive 12-month safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001, a potential first-in-class gene therapy blocking interleukin 1 (IL-1) for the treatment of knee osteoarthritis (OA).
Biotech Industry in Gainesville Is Booming
Gainesville's booming biotech industry, bolstered by UF Innovate's incubators and a supportive business environment, showcases the success of UF-affiliated startups and the city's commitment to innovation and entrepreneurship.
Find Out Why Entrepreneurs in Gainesville Thrive Here
Gainesville’s thriving entrepreneurial ecosystem, supported by UF Innovate, is exemplified by the success of UF startup MYOLYN, known for its rehabilitation technology, and UF Innovate | Accelerate client Slice Engineering, a leader in 3D printing components.
Kriya Presents Data at the 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
UF startup Kriya Therapeutics, Inc., presented preclinical data on its gene therapy candidate, KRIYA-825, being developed for the treatment of Geographic Atrophy.
LightPath Technologies Secures $4.9 Million Order for Infrared Cameras With an Existing Defense Customer
UF startup LightPath Technologies, Inc., announced its subsidiary G5 Infrared, a leading high-end infrared camera systems manufacturer, received a $4.9 million follow-on order from an existing defense industry customer.
NovaBone Announces Strategic Partnership With Summit Products Group To Distribute NovaForm® Wound Matrix in the U.S.
UF startup NovaBone Products, a leading developer of biomaterials for regenerative medicine, announced that it has entered into a long-term strategic partnership with Summit Products Group, a national provider of advanced wound care solutions.
Myosin Therapeutics Awarded $3 Million NIH Grant To Advance Clinical Trial for MT-110 in Methamphetamine Use Disorder
UF Startup Myosin Therapeutics, Inc., a biotechnology company developing innovative therapies for cancer and neurological disorders, announced that it has been awarded a $3 million grant from NIDA, part of NIH.
The Fibrolamellar Cancer Foundation Establishes Partnership With Dialectic Therapeutics
UF startup Dialectic Therapeutics, in partnership with the Fibrolamellar Cancer Foundation (FCF), will supply the experimental drug DT2216 for a clinical trial involving fibrolamellar patients.
